|
Volumn 19, Issue 11, 2013, Pages 905-907
|
Zinc monotherapy and a low-copper diet are beneficial in patients with Wilson disease after liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
BACLOFEN;
BILIRUBIN;
CERULOPLASMIN;
CLONAZEPAM;
COPPER;
GLUCONATE ZINC;
LEVODOPA;
PENICILLAMINE;
TACROLIMUS;
TRIHEXYPHENIDYL;
WILSON DISEASE PROTEIN;
CHELATION THERAPY;
CLINICAL FEATURE;
COPPER BLOOD LEVEL;
DECOMPENSATED LIVER CIRRHOSIS;
DEPRESSION;
DIET SUPPLEMENTATION;
DIETARY INTAKE;
DYSARTHRIA;
DYSPHAGIA;
DYSTONIA;
EDEMA;
FOLLOW UP;
FULMINANT HEPATIC FAILURE;
GENOTYPE;
HUMAN;
HYPERSALIVATION;
JAUNDICE;
LETTER;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER DYSFUNCTION;
LIVER FUNCTION TEST;
LIVER TRANSPLANTATION;
MONOTHERAPY;
MUTATIONAL ANALYSIS;
NEUROLOGIC DISEASE;
POSTOPERATIVE PERIOD;
SLURRED SPEECH;
SPLENOMEGALY;
TORSION DYSTONIA;
TREMOR;
WILSON DISEASE;
ADOLESCENT;
ADULT;
COPPER;
DIET;
FEMALE;
HEPATOLENTICULAR DEGENERATION;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
YOUNG ADULT;
ZINC;
|
EID: 84885917985
PISSN: 17555930
EISSN: 17555949
Source Type: Journal
DOI: 10.1111/cns.12167 Document Type: Letter |
Times cited : (9)
|
References (9)
|